These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1009 related items for PubMed ID: 15312156

  • 1. Differential time effect profiles of amlodipine, as compared to valsartan, revealed by ambulatory blood pressure monitoring, self blood pressure measurements and dose omission protocol.
    Radauceanu A, Boivin JM, Bernaud C, Fay R, Zannad F, CIC General Practitioners Investigators' Group.
    Fundam Clin Pharmacol; 2004 Aug; 18(4):483-91. PubMed ID: 15312156
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM, Malacco E, Khder Y, Kandra A, Bönner G, Heintz D.
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [Abstract] [Full Text] [Related]

  • 3. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P, Dorigatti F, Mugellini A, Spagnuolo V, Varì N, Ferrara R, Bertocchi F.
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [Abstract] [Full Text] [Related]

  • 4. Two multicenter, 8-week, randomized, double-blind, placebo-controlled, parallel-group studies evaluating the efficacy and tolerability of amlodipine and valsartan in combination and as monotherapy in adult patients with mild to moderate essential hypertension.
    Philipp T, Smith TR, Glazer R, Wernsing M, Yen J, Jin J, Schneider H, Pospiech R.
    Clin Ther; 2007 Apr; 29(4):563-80. PubMed ID: 17617280
    [Abstract] [Full Text] [Related]

  • 5. Tolerability and blood pressure-lowering efficacy of the combination of amlodipine plus valsartan compared with lisinopril plus hydrochlorothiazide in adult patients with stage 2 hypertension.
    Poldermans D, Glazes R, Kargiannis S, Wernsing M, Kaczor J, Chiang YT, Yen J, Gamboa R, Fomina I.
    Clin Ther; 2007 Feb; 29(2):279-89. PubMed ID: 17472820
    [Abstract] [Full Text] [Related]

  • 6. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
    Lacourcière Y, Wright JT, Samuel R, Zappe D, Purkayastha D, Black HR, EVALUATE study.
    Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
    [Abstract] [Full Text] [Related]

  • 7. Effect of valsartan or olmesartan addition to amlodipine on ankle edema in hypertensive patients.
    Fogari R, Malamani G, Corradi L, Mugellini A, Preti P, Zoppi A, Derosa G.
    Adv Ther; 2010 Jan; 27(1):48-55. PubMed ID: 20174905
    [Abstract] [Full Text] [Related]

  • 8. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive efficacy and tolerability of two fixed-dose combinations of valsartan and hydrochlorothiazide compared with valsartan monotherapy in patients with stage 2 or 3 systolic hypertension: an 8-week, randomized, double-blind, parallel-group trial.
    Lacourcière Y, Poirier L, Hebert D, Assouline L, Stolt P, Rehel B, Khder Y.
    Clin Ther; 2005 Jul; 27(7):1013-21. PubMed ID: 16154480
    [Abstract] [Full Text] [Related]

  • 10. [Antihypertensive effect of valsartan 80 mg and hydrochlorothiazide 12.5 mg evaluated by ambulatory blood pressure monitoring].
    Vaïsse B, Ghobrial H, Vaur L, Poncelet P, Asmar R, Herpin D, Mallion JM.
    Arch Mal Coeur Vaiss; 2001 Aug; 94(8):907-12. PubMed ID: 11575229
    [Abstract] [Full Text] [Related]

  • 11. Valsartan, a new angiotensin II antagonist for the treatment of essential hypertension: a comparative study of the efficacy and safety against amlodipine.
    Corea L, Cardoni O, Fogari R, Innocenti P, Porcellati C, Provvidenza M, Meilenbrock S, Sullivan J, Bodin F.
    Clin Pharmacol Ther; 1996 Sep; 60(3):341-6. PubMed ID: 8841157
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of the combination valsartan/hydrochlorothiazide compared with amlodipine in a mild-to-moderately hypertensive Brazilian population.
    Franco RJ, Goldflus S, McQuitty M, Oigman W, Valsartan/HCTZ Combination Therapy in Brazil Study Group.
    Blood Press Suppl; 2003 Dec; 2():41-7. PubMed ID: 14761076
    [Abstract] [Full Text] [Related]

  • 13. Amlodipine/valsartan/hydrochlorothiazide triple combination therapy in moderate/severe hypertension: Secondary analyses evaluating efficacy and safety.
    Calhoun DA, Crikelair NA, Yen J, Glazer RD.
    Adv Ther; 2009 Nov; 26(11):1012-23. PubMed ID: 20024680
    [Abstract] [Full Text] [Related]

  • 14. Ambulatory blood pressure-lowering effects of valsartan and enalapril after a missed dose in previously untreated patients with hypertension: a prospective, randomized, open-label, blinded end-point trial.
    Hermida RC, Ayala DE, Khder Y, Calvo C.
    Clin Ther; 2008 Jan; 30(1):108-20. PubMed ID: 18343247
    [Abstract] [Full Text] [Related]

  • 15. Effect of valsartan addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients.
    Fogari R, Zoppi A, Derosa G, Mugellini A, Lazzari P, Rinaldi A, Fogari E, Preti P.
    J Hum Hypertens; 2007 Mar; 21(3):220-4. PubMed ID: 17215848
    [Abstract] [Full Text] [Related]

  • 16. Antihypertensive efficacy and safety of olmesartan medoxomil compared with amlodipine for mild-to-moderate hypertension.
    Chrysant SG, Marbury TC, Robinson TD.
    J Hum Hypertens; 2003 Jun; 17(6):425-32. PubMed ID: 12764406
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of combination therapy with valsartan/hydrochlorothiazide in the initial treatment of severe hypertension.
    Calhoun DA, Glazer RD, Pettyjohn FS, Coenen PD, Zhao Y, Grosso A.
    Curr Med Res Opin; 2008 Aug; 24(8):2303-11. PubMed ID: 18593517
    [Abstract] [Full Text] [Related]

  • 18. Aliskiren, an orally effective renin inhibitor, provides antihypertensive efficacy alone and in combination with valsartan.
    Pool JL, Schmieder RE, Azizi M, Aldigier JC, Januszewicz A, Zidek W, Chiang Y, Satlin A.
    Am J Hypertens; 2007 Jan; 20(1):11-20. PubMed ID: 17198906
    [Abstract] [Full Text] [Related]

  • 19. A comparison of the effects of fixed dose vs. single-agent combinations on 24-h blood pressure variability.
    Ulusoy S, Ozkan G, Konca C, Kaynar K.
    Hypertens Res; 2012 Nov; 35(11):1111-7. PubMed ID: 22786565
    [Abstract] [Full Text] [Related]

  • 20. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
    J Hum Hypertens; 2004 Mar; 18(3):215-22. PubMed ID: 14973517
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.